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ABSTRACT
Patient safety in hospital care depends on effective infection control (IC) programmes. The
Antimicrobial Resistance Prevention and Control (ARPAC) study assessed the organisation,
components and human resources of IC programmes in European hospitals. A questionnaire survey
of policies and procedures implemented in 2001 for the surveillance and control of nosocomial
infection and antibiotic resistance was completed by 169 acute-care hospitals from 32 European
countries, categorised by five geographical regions. A formal IC programme existed in 72% of
hospitals, and a multidisciplinary IC committee was operational in 90%. Trained IC nurses (ICNs)
were present in 80% of hospitals (ranging from 54% in south-east and central-eastern Europe, to
100% in northern Europe), whereas 74% had one or more trained IC doctors (ICDs) (ranging from
46% in south-east Europe to 84% in western Europe). Median staffing levels were 2.33 ICNs ⁄ 1000
beds and 0.94 ICDs ⁄ 1000 beds. The intensity of IC programmes scored higher in centres from
northern and western Europe than from other European regions. Written guidelines promoted hand
hygiene for healthcare workers in 89% of hospitals, education in 85%, and audit in 46%. Guidelines
recommended use of alcohol-based solutions (70%) and ⁄ or medicated ⁄ antiseptic soap (43%) for
decontamination of non-soiled hands. Use of alcohol-based solutions varied according to region,
from 41% in southern Europe to 100% in northern Europe, compared with use of medicated soap
from 77% in southern Europe to 11% in northern Europe (p < 0.01). These findings showed that IC
programmes in European hospitals suffer from major deficiencies in human resources and policies.
Staffing levels for ICNs were below recommended standards in the majority of hospitals. Education
programmes were incomplete and often not supported by audit of performance. Hand hygiene
procedures were sub-standard in one-third of centres. Strengthening of IC policies in European
hospitals should be a public health priority.
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INTRODUCTION
Antimicrobial resistance is fuelled by selection
and transmission of antimicrobial-resistant bac-
teria in acute-care hospitals, where they add to
the health and economic burden of nosocomial
infection [1]. Acknowledgement of this threat has
prompted publication of recommendations and
action plans by national and international health
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agencies [2,3]. These recommendations call for
prudent use of antimicrobial agents, as well as
better prevention and control of infection. How-
ever, the public and the media express growing
concern about the safety of hospital care and the
effectiveness of infection prevention programmes.
The Antibiotic Resistance Prevention and Con-
trol (ARPAC) project was a Concerted Action
supported by the European Commission and
carried out by four Study Groups of the European
Society of Clinical Microbiology and Infectious
Diseases (ESCMID), namely the ESCMID Study
Group on Antibiotic Policies (ESGAP), the ESC-
MID Study Group for Antimicrobial Resistance
Surveillance (ESGARS), the ESCMID Study
Group on Nosocomial Infections (ESGNI), and
the ESCMID Study Group on Epidemiological
Markers (ESGEM). The ARPAC study was
launched in 2002, with the aims of laying the
foundations for a better understanding of the
causes of variations in the prevalence and spread
of antibiotic resistance, and of evaluating and
harmonising strategies for prevention and control
of antibiotic-resistant pathogens in hospitals in
Europe. One specific objective of ARPAC was to
describe the general hospital infection control (IC)
infrastructure, organisation, policies and proce-
dures implemented in acute-care hospitals
throughout Europe. This paper presents the
retrospective data for 2001 from participating
ARPAC hospitals in 32 European countries,
including old and new European Union (EU)
member states and non-EU member states.
MATERIALS AND METHODS
Study population
The ESCMID Membership Directory (n = > 2500 entries) was
used as the sampling frame for hospital recruitment; a
recruitment flyer and initial screening questionnaire were
circulated in 2002. In total, 263 European hospitals expressed
an interest in participating. Data concerning hospital charac-
teristics, including hospital size, case-mix, annual admissions
and teaching status were obtained. These characteristics were
compared with WHO and EU hospital datasets in an attempt
to assess the representativeness and generalisability of the
eventual recruited ARPAC sample.
Questionnaire survey
In 2003–2004, a series of questionnaires was sent to 263
registered ARPAC participants to collect retrospective hospital
data for the year 2001 concerning: (a) antimicrobial suscepti-
bility testing methods and antibiotic resistance rates; (b)
antibiotic prescribing policies and antibiotic consumption
data; (c) IC policies and practices; and (d) methods used for
surveillance and control of selected antimicrobial-resistant
pathogens with transmission potential, termed ‘alert’ organ-
isms. This report is based on the results from questionnaire (c),
which was completed by a qualified physician responsible for
hospital IC or another delegated individual.
The IC questionnaire was developed in English by the
ARPAC Steering Group and was piloted twice on a sub-
sample of ten acute-care hospitals in different countries. Data
relating to 2001 were collected concerning the following items:
infection control management and organisation (11 questions);
standard IC precautions for clinical staff (13 questions); audit
and feedback on IC policies (seven questions); education
programme (six questions); and IC staffing level (five ques-
tions). Following design modifications, the final version was
mailed to participants in early 2003. Questionnaires were
returned, either by mail or by Fax, by the deadline of 30
September 2003.
Statistical analysis
Data were entered into Microsoft Access 2000, and an
independent validation check was made on a 10% sample.
Statistical analysis was conducted using Epi-Info v.6 software
(CDC, Atlanta, GA, USA). Descriptive analysis was conducted
to identify associations between key IC factors and geograph-
ical ⁄hospital factors, including hospital size, teaching status
and case-mix variables, with p < 0.01 considered to be
statistically significant. Data were analysed by European
region using a modified standard European reference system
[4], with hospitals from the UK categorised as part of western
rather than northern Europe (Table 1). Assessment of regional
representativeness was estimated using 2001 European bed
data from EUROSTAT (http://www.euro.who.int). Hospital
size was categorised as small (< 500 beds), medium (500–1000)
or large (> 1000 beds). Descriptive statistics were conducted
using medians and inter-quartile range (IQR), and statistical
testing was conducted using non-parametric, Mann–Whitney
U and Kruskal–Wallis tests.
IC policy score
An IC policy score was developed a priori, based on a
weighting system from previous validation projects (HAR-
MONY; http://www.hospitalhealthcare.com). Criteria contri-
buting to the scoring system included: number of departments
represented in the Infection Control Committee (ICC); full-
time equivalent (FTE) infection control nurses (ICNs) ⁄ beds;
FTE infection control doctors (ICDs) ⁄ beds; training of IC staff;
surveillance programme; specific precautions for alert organ-
isms; and standard IC precautions (hand hygiene
policy ⁄ audit ⁄ feedback). An IC scale of 0–20 was divided into
no IC input (score 0), low (1–8), medium (9–15) or high IC
input (16–20). Scores were explored by geographical region
and hospital characteristics.
RESULTS
Hospital characteristics
Complete IC data were received from 169 (64%)
of 263 participating hospitals in 32 European
730 Clinical Microbiology and Infection, Volume 12 Number 8, August 2006
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 729–737
countries (Table 1). Responding hospitals
(n = 169) were more likely than non-responding
hospitals recruited to the ARPAC study (n = 94)
to have teaching status (p 0.03), but there were no
differences according to geographical region (p
0.47), hospital size (p 0.81), and presence or size of
ICU (p 0.14). The majority of participating hospi-
tals had teaching status and offered intensive
care, medical and surgical services (Table 2).
Hospital size was distributed evenly across geo-
graphical regions, with a median of 659 (IQR, 114,
1014) beds.
IC committee
The majority (n = 152; 90%) of hospitals had an
IC Committee with multidisciplinary participa-
tion from clinical microbiology and infectious
disease departments, clinical departments, ICNs,
hospital epidemiology ⁄ ICDs, pharmacy, the
hospital’s Chief Executive and others (Table 3).
There were significant regional differences in the
composition of the committee: hospitals from
central-eastern Europe were less likely to have
participation from IC staff compared with hospi-
tals in northern and western Europe, whereas
infectious disease specialists were more likely to
participate in committees from southern and
south-eastern Europe (p < 0.01).
IC staff
In total, 134 (79%) hospitals reported ICNs who
had received specific training in IC. There were
regional differences, with hospitals in southern
and south-eastern Europe being less likely to have
trained ICNs compared with other regions
(Table 4). The majority of hospitals (n = 120;
71%) reported an ICD with specific IC training;
a similar geographical trend in distribution of
hospitals with ICDs was noted (Table 4).
The median ICN-to-bed ratio was 2.33
ICNs ⁄ 1000 beds (IQR 1.57, 3.48). Only 27 ⁄ 145
(18%) of evaluable hospitals reported more than
one ICN for 250 beds. Nine hospitals reported
having no ICNs, and 15 (9%) failed to provide
data. There were only minor variations in ICN
staffing levels among geographical regions. The
median ICD-to-bed ratio was 0.94 ICDs ⁄ 1000 beds
(IQR 0.40, 1.69). The presence of at least one
ICD ⁄ 1000 beds was reported by 67 (40%) health-
care facilities, with only 15 ⁄ 147 (10%) of evalua-
ble hospitals having more than one ICD ⁄ 250 beds.
A total of 25 (15%) hospitals reported having no
ICD, and 17 (10%) hospitals failed to provide
data. Fig. 1 displays median ICN and ICD num-
bers ⁄ 250 beds according to training status and
geographical region.
Link nurses
A link nurse, defined as a nurse working on the
ward who liaises with the IC team on a regular
basis, was reported by 77 (46%) of participating
hospitals. In 47 (28%) hospitals, the link nurse
Table 1. ARPAC hospitals providing infection control
data by European region and country (n = 169)
European region Country No. hospitals (%)
North Denmark 5
Norway 3
Sweden 4
The Netherlands 7
Region total 19 (11)
West Austria 5
Belgium 18
France 6
Germany 10
Swizerland 5
UK 11
Region total 55 (33)
South-East Bosnia-Herzegovina 2
Croatia 6
Macedonia 1
Yugoslavia 4
Region total 13 (8)
South Greece 7
Italy 9
Malta 1
Portugal 2
Spain 8
Israel 2
Turkey 10
Region total 39 (23)
Central-East Bulgaria 7
Czech Republic 3
Hungary 7
Poland 6
Romania 2
Russia 1
Slovakia 5
Slovenia 5
Estonia 2
Latvia 2
Lithuania 3
Region total 43 (25)
Table 2. ARPAC hospital characteristics (n = 169)
Characteristic n (%)
Hospital size < 500 beds 61 (37)
500–1000 beds 59 (36)
> 1000 beds 43 (26)
Missing data 6 (4)
Teaching status Teaching 130 (77)
Non-teaching 33 (20)
Missing data 6 (4)
Specialised care ICU beds 158 (94)
Medical beds 149 (88)
Surgical beds 156 (92)
Paediatric beds 121 (72)
Struelens et al. Hospital infection control policies in Europe 731
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 729–737
system was deployed for the entire hospital.
There was no significant geographical variation
in the implementation of this system (p > 0.01).
IC programme
The existence of an IC programme with annual
objectives and progress reports was reported by
122 (72%) hospitals. In approximately two-thirds
of hospitals (116; 69%), senior management
received and ⁄ or reviewed the IC annual report.
Over half of participating hospitals (98; 58%)
reported that senior management were ultimately
responsible for delivery of the IC programme.
There was no significant variation according to
region, size or teaching status for any aspect of the
IC programmes.
Standard IC precautions
Written guidelines for standard precautions taken
by healthcare workers were available in 127 (75%)
of hospitals during 2001. Components of these
Table 3. Composition of the Infec-
tion Control Committee in ARPAC
hospitals, grouped according to
European region
Representation
North
n = 19 (%)
West
n = 55 (%)
South
n = 39 (%)
South-east
n = 13 (%)
Central-east
n = 43 (%)
All regions
n = 169 (%)
Medical microbiology 17 (90) 48 (87) 36 (92) 12 (92) 34 (79) 147 (87)
Clinical department 15 (79) 46 (84) 33 (85) 11 (85) 30 (70) 135 (80)
IC nurse 14 (74a) 50 (91a) 35 (90a) 10 (77a) 18 (42 a) 127 (75)
IC doctor 12 (63a) 50 (91a) 18 (46a) 7 (54*) 21 (49 a) 108 (64)
Pharmacy 9 (47a) 36 (66a) 31 (80a) 4 (31 a) 21 (49 a) 104 (62)
Chief Executive 9 (47a) 36 (66a) 30 (77a) 8 (62a) 16 (37 a) 99 (59)
Infectious diseases 11 (58a) 26 (47a) 31 (80a) 10 (77a) 17 (40 a) 95 (56)
Hospital epidemiology 5 (26a) 20 (36a) 8 (21a) 10 (77*) 11 (26 a) 54 (32)
Maintenance 6 (32a) 29 (53a) 10 (26a) 0 (0) 6 (14 a) 51 (30)
Occupational health 10 (53a) 31 (56) 6 (15) 2 (15) 0 (0) 49 (29)
Public health doctor 2 (11) 13 (24) 5 (13) 1 (8) 3 (7) 24 (14)
ap 0.01, chi-square test. IC, infection control.
Table 4. Proportion of ARPAC hospitals reporting the
presence of trained infection control nurses (ICNs) and
infection control doctors (ICDs) during 2001
Trained ICNs
n = 134 (%)
Trained ICDs
n = 120 (%)
Geographical region
North 17 (90a) 14 (74a)
West 55 (100a) 46 (84a)
South 32 (82a) 27 (69a)
South-east 7 (54a) 6 (46a)
Central-east 23 (54a) 27 (63a)
Teaching status
Teaching 100 (77) 94 (72)
Non-teaching 28 (85) 23 (70)
Hospital size
Small 43 (71) 36 (59)
Medium 51 (86) 46 (78)
Large 35 (81) 34 (79)
ap 0.01, chi-square test.
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Fig. 1. (A) Median full-time equivalent (FTE) infection control nurses (ICNs) ⁄ 250 beds, with and without special infection
control training, grouped according to European geographical region. (B) Median infection control doctors (ICDs) ⁄ 250
beds, with and without special infection control training, grouped according to European geographical region.
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policies for hand hygiene procedures showed
significant differences among regions (Table 5):
alcohol-based solutions for non-soiled hands were
recommended mainly by hospitals in northern,
western and central-eastern Europe; medic-
ated ⁄ antiseptic and plain soap were recommen-
ded more frequently in southern Europe; and all
products were recommended frequently in south-
eastern Europe.
More than 88% of hospitals recommended that
healthcare workers should wear gloves for all
contact with blood, body fluids and mucous
membranes. A lower proportion of hospitals
(124; 73%) recommended wearing gloves for
contact with non-intact skin, with significant
regional variation; hospitals in northern and
western Europe were more likely to recommend
gloves than those in central-eastern Europe
(p < 0.01). Policies also recommended that health-
care workers wash or disinfect hands after
removing gloves (152; 90%), with a similar fre-
quency according to region, hospital size and
teaching status.
Hospitals were asked to report how often
hand hygiene policies were updated: approxi-
mately one-third of hospitals (51; 30%) reported
that policies had been updated during the
previous 3 years; 34 (20%) reported updates
during the past 3–5 years; and 26 (15%) reported
longer time intervals (58 (34%) missing re-
sponses). There were no differences in frequency
of policy revision according to region, size or
teaching status.
A variety of educational, logistical and com-
munication methods were used to promote hand
hygiene, with significant regional variations
(Table 6). In particular, logistical support in terms
of providing hand hygiene products at the bed-
side and facilitating the skin care of healthcare
workers was reported more frequently in hospi-
tals in northern and western Europe. There were
no differences in the methods used according to
hospital size or teaching status.
IC procedures
Most hospitals reported having written protocols
for IC procedures concerning: (a) basic IC (117;
70%); (b) room cleaning (120; 71%); (c) screening
for multiresistant organisms (90; 53%); and (d)
isolation of patients with alert organisms (106;
63%). There was significant geographical vari-
ation with respect to the presence of protocols
(except for alert organism screening), with higher
frequencies in northern and western Europe
compared with south-eastern and central-eastern
Europe (p < 0.01).
Surveillance and feedback
Surveillance of nosocomial infections and alert
organisms was performed by 125 (74%) and 124
(73%) centres, respectively, with no significant
regional differences. However, only 64 (38%)
Table 6. Methods used to promote hand hygiene among hospital staff, grouped according to European region
Method
North
n = 19
West
n = 55
South
n = 39
SE
n = 13
CE
n = 43
All regions
n = 169 (%)
HCW education ⁄ in-service training 18 (95a) 50 (91a) 32 (82a) 9 (69a) 33 (77a) 142 (84)
Routine observation ⁄ feedback on compliance 2 (11a) 30 (55a) 17 (44a) 7 (54a) 22 (52a) 78 (46)
HH products available by patient bedside 16 (84a) 44 (80a) 22 (56a) 5 (39a) 21 (49a) 108 (64)
Reminders in work places or posters 9 (47) 41 (75) 24 (62) 9 (69) 26 (61) 109 (65)
Rewards for good performance 0 (0) 2 (2) 3 (7) 2 (15) 1 (2) 8 (5)
Administrative sanction for poor performance 0 (0) 0 (0) 2 (5) 1 (8) 6 (14) 9 (5)
Promotion ⁄ facilitating HCW’s skin care 10 (53a) 26 (47a) 9 (23a) 4 (31) 9 (1a) 58 (34)
Written guidelines 15 (79a) 49 (89a) 28 (72a) 9 (69a) 28 (65a) 129 (76)
Encouragement from key staff ⁄ clinical leaders 6 (32) 25 (6) 16 (41) 3 (23) 11 (26) 61 (36)
Targeting groups with poor compliance 1 (5) 10 (18) 6 (15) 1 (8) 3 (7) 21 (12)
ap 0.01, chi-square test; column percentages presented.
HCW, healthcare worker; HH, hand hygiene; SE, South-east; CE, Central-east.
Table 5. Products recommended to healthcare staff for
hand hygiene, grouped according to European region
Recommended product
North
n = 19
West
n = 55
South
n = 39
SE
n = 13
CE
n = 43
All regions
n = 169 (%)a
Plain soap 11 (58b) 16 (29b) 15 (39b) 8 (62b) 14 (33b) 64 (38)
Medicated ⁄ antiseptic soap 2 (11c) 12 (22c) 30 (77c) 8 (62c) 21 (49c) 73 (43)
Alcohol-based solutions
for non-soiled hands
19 (100c) 39 (71c) 16 (41c) 9 (69c) 35 (81c) 118 (70)
Alcohol-based gel ⁄ foam
for non-soiled hands
4 (21b) 14 (26b) 1 (3b) 0 (0b) 10 (26b) 29 (17)
No recommendation 0 (0) 1 (2) 0 (0) 0 (0) 1 (2) 2 (1)
aTotal answering ‘yes’ to recommended product.
bp < 0.05; cp < 0.01, chi-square test.
SE, South-east; CE, Central-east.
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hospitals produced epidemiology reports during
2001 concerning the prevalence of patients colo-
nised or infected with alert organisms, and only
40 (24%) hospitals presented such reports to
clinical staff with data broken down by depart-
ment. In two-thirds of hospitals (112; 66%), the IC
team provided regular activity reports to the IC
committee. Hospitals in northern and western
Europe were more likely to provide these reports
than institutions in south-eastern and central-
eastern Europe (p < 0.01).
Education
Educational sessions for healthcare workers con-
cerning IC practices were reported by 131 (77%)
centres. These targeted mainly qualified nurses
(71%), junior medical staff (51%), cleaning staff
(52%), unqualified nursing assistants (51%),
medical students (39%) and link nurses (38%),
with higher frequencies found in northern and
western Europe than in south-eastern and central-
eastern Europe (p < 0.01). Attendance at these
educational sessions was generally not recorded,
either for doctors (89%) or nurses (72%). Feed-
back of audit data in educational sessions was
infrequent (29%). Only 91 (54%) participants
included IC policies in the programme of induc-
tion training for clinical staff.
IC scoring
IC policy scores (range, 0–20) were calculated for
each healthcare institution (missing data for 12
hospitals). The median IC score was 9.0 (IQR 7,
11). The intensity of IC programmes appeared
higher in northern and western Europe than in
other regions, although this difference did not
achieve statistical significance (Table 7). There
were no differences in scores according to teach-
ing status or hospital size.
Implementation problems
Problems in implementing IC policies during
2001 were reported by the majority of hospitals,
and included: (a) an insufficient number of
isolation rooms (142; 84%), which was an occa-
sional problem for most hospitals in northern and
western Europe and a permanent problem for
most hospitals in central-eastern Europe; (b)
non-compliance with hand hygiene procedures
(132; 78%), which appeared to be a problem in all
regions; (c) a lack of skilled staff (117; 69%),
which was an occasional problem for most hos-
pitals in southern and western Europe, and a
permanent problem for most hospitals in south-
eastern Europe; and (d) poor compliance with
procedures for decontaminating the environment
in patients’ rooms (66; 39%).
DISCUSSION
This is the largest survey conducted to date to
ascertain current organisation, resources and
policies for IC in European hospitals. Major
deficiencies were observed, despite the fact that
the self-selected sample in this survey was biased
towards large academic centres with, presumably,
better than average resources [5]. Some key
elements of well-organised IC programmes were
generally evident, such as guidance by a multi-
disciplinary prevention and control-of-infection
committee, management support and an annual
activity programme, including surveillance of
nosocomial infection and staff training [6,7]. In
contrast, audit of procedures and feedback of
surveillance data were uncommon practices, and
trained IC staffing resources were below recom-
mended standards in the majority of hospitals
[6–8]. The use of alcohol-based hand rubs, which
is the current standard for routine hand hygiene,
was not included within the IC policy in one-third
of hospitals. Hand hygiene promotion pro-
grammes were incomplete and marked regional
variations were found. Resource deficit and
sub-standard policies were more frequent in
hospitals in south-eastern and central-eastern
Europe than in northern and western Europe.
These findings have important policy impli-
cations at the local, national and European levels
in terms of promoting patient safety and contain-
ing antimicrobial resistance in the acute-care
setting.
Table 7. Level of infection control input according to
European region
IC score for level
of input
North
n = 19
(%)
West
n = 55
(%)
South
n = 39
(%)
SE
n = 13
(%)
CE
n = 43
(%)
All regions
n = 169
(%)
Low (1–8) 5 (29a) 4 (7a) 6 (16a) 4 (40a) 9 (22a) 28 (17)
Medium (9–15) 6 (35a) 33 (64a) 26 (70a) 6 (60a) 27 (66a) 98 (58)
High (16–20) 6 (35a) 15 (29a) 5 (14a) 0 (0a) 5 (12a) 31 (18)
ap 0.02, chi-square test; 12 (7%) hospitals had missing data.
SE, South-East; CE, Central-East.
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There are several methodological aspects of this
study that deserve comment. First, this survey
was unique in its geographical breadth, in that it
encompassed 32 countries across Europe, located
both within and outside the EU, and included a
large sample of hospitals. Data collection was
performed using validated definitions to improve
consistency, with international reporting from
diverse healthcare systems. Data collection tools
were developed by an experienced international
group of clinical scientists from complementary
disciplines. These tools were piloted by hospital
practitioners from different European regions to
test their feasibility, clarity and potential for
measurement error. It should also be emphasised
that data analysis used a conservative statistical
cut-off point to adjust for multiple hypothesis
testing.
However, the study also has limitations, and
some findings should be interpreted with caution.
The hospitals were self-selecting, which increases
the risk for selection and response bias, and may
not entirely reflect variation in IC policies
throughout Europe. In particular, there was an
over-representation of teaching hospitals in the
study. Ideally, a full listing of all acute-care
hospitals in Europe would provide a sampling
frame for random selection of eligible hospitals,
but no such list exists, and therefore alternative
approaches were used for hospital recruitment.
The use of specialist membership lists is a
recognised method for sampling in research
studies, although this method does not ensure
that all members of the target population are
covered [5]. Country-level hospital data, partic-
ularly numbers of acute-care beds, were obtained
from EUROSTAT (http://www.euro.who.int) for
comparative purposes; however, the classification
and definition of ‘acute-care’ beds varies among
countries. The crude estimated coverage of beds
in the ARPAC study was 10% or less per region,
but for many countries, the EUROSTAT denom-
inator value included psychiatric, long-stay and
community beds. The actual coverage per region
is therefore probably higher than the value esti-
mated above. However, variation in response
rates by country or region may have compro-
mised the regional representativeness of partici-
pating hospitals. There was potential for recall
bias, as questionnaires asking about policies for
2001 were distributed in early 2003. A final
consideration relates to the questionnaire design,
since it collected self-reported policies, which
should not be misrepresented as measuring actual
behaviour. Thus, it should be emphasised that
this report provides a picture of IC policies that is
likely to overestimate the intensity of practices in
European hospitals during 2001.
Effectively reducing the risk of healthcare-
associated infection and the spread of antibiotic-
resistant pathogens depends critically on
professional IC services. In the 1970s, the SENIC
study [6] identified the first evidence-based struc-
tural components of effective IC programmes: the
availability of a physician with specific training in
hospital epidemiology and IC, also referred to as
an infection control doctor (ICD); a minimum of
one full-time IC practitioner, who often has a
nursing background and is therefore referred to
as an infection control nurse (ICN), per 250
occupied acute-care beds; a hospital-wide con-
tinuous surveillance system for nosocomial infec-
tion; and feedback of surveillance data to the
relevant healthcare workers and a structured
prevention plan. More recently, these require-
ments have been revised and refined, based on
expert opinion, to propose more cost-effective
approaches for surveillance and to take into
account the increasingly complex delivery of
hospital and ambulatory care, increased turnover,
increased severity of illness in the hospitalised
patient population, and epidemic spread of anti-
biotic-resistant pathogens. In 1998, professional
organisations in the USA and the CDC published
consensus guidelines that defined the key func-
tions of effective IC programmes: targeted sur-
veillance of nosocomial infection; detection and
control of outbreaks; setting, implementing and
auditing written policies for IC; and education
and training of healthcare workers [7]. These
guidelines also stated that IC personnel should be
recruited in proportion to the estimated risk for
the population served by the institution. Cana-
dian IC experts developed a model to quantify the
staffing needs for effective IC programmes, and
suggested that general hospitals would require
one full-time ICN ⁄ 167 acute-care beds [8]. A
panel of experts from ESGNI reported that the
average 2004 national standards among 12 Euro-
pean countries were 1.2 ICDs and 3.4 ICNs ⁄ 1000
beds, respectively, whereas estimated require-
ments were higher at 1.8 ICDs and 4.2 ICNs ⁄ 1000
beds, respectively, with an additional 3.3
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co-workers ⁄ 1000 beds for data management and
administrative support [9].
In the present survey, 90% of hospitals had a
multidisciplinary IC committee in operation, and
more than two-thirds had annual action plans and
hospital management support. Three-quarters of
hospitals in the ARPAC study conducted a
surveillance programme for nosocomial infections
and antibiotic resistance. These findings are less
impressive than those in Canada, where 92% and
94% of hospitals operated surveillance systems in
2000 for nosocomial infection and methicillin-
resistant Staphylococcus aureus infection rates,
respectively. According to current guidelines,
most European hospitals in the ARPAC study
had grossly insufficient resources in terms of
ICNs and ICDs. Only 17% of facilities had at least
one ICN ⁄ 250 beds, as recommended in SENIC,
with a median of one ICN ⁄ 430 beds. These
staffing levels appear better than the median
ICN-to-bed ratio of 1 ⁄ 503 and 1 ⁄ 617 reported
5 years earlier in western and eastern European
hospitals, respectively [10], but this staffing ratio
is low compared with the figure of 58% of
Canadian hospitals that met this SENIC recom-
mendation, with a median of one ICN ⁄ 244 beds in
2000 [11]. ICD staffing appeared better in the
present survey, which suggested that 71% of
hospitals in the ARPAC study had specially
trained physicians (MDs), compared with 14%
of US hospitals in 1996 and 60% of Canadian
hospitals in 2000 that had an MD or scientist
(PhD) with IC training [11,12]. However, IC
training is not formally certified as a medical
specialty in most countries, and may vary sub-
stantially in content and expertise [9]. This train-
ing deficiency has been addressed by ESCMID,
which published recommendations for national
IC training programmes for infection specialists
and provides international training courses in
hospital epidemiology [9,13].
Compliance with standard precautions, inclu-
ding efficient hand hygiene techniques and bar-
rier measures, is the cornerstone for prevention of
cross-infection by healthcare providers [14–16].
The ARPAC study clearly identified efforts by the
vast majority of European IC programmes, espe-
cially in northern and western Europe, to estab-
lish guidelines and train healthcare staff in these
procedures. Current guidelines recommend the
use of alcohol-based hand rubs as the standard of
care for decontaminating non-soiled hands [15].
In 2001, this was part of the local policy in 70% of
European hospitals, but with marked regional
differences. The use of medicated soap was still
recommended in a majority of hospitals in south-
ern Europe, despite the numerous disadvantages
of these products. Methods used for promoting
adherence to hand hygiene also varied signifi-
cantly according to region, with a stronger
emphasis in northern and western Europe on
making antiseptics available at the bedside and
promoting the skin care of healthcare workers,
two factors that have proved crucial for improv-
ing compliance [15]. A majority (78%) of ARPAC
hospitals reported encountering the problem of
insufficient compliance with hand hygiene. Strat-
egies to improve hand hygiene compliance must
include staff education and motivation, the use
of performance indicators, and hospital man-
agement support [15]. It is therefore important
to address the deficiencies apparent in the
majority of programmes described in the AR-
PAC participating hospitals, which fail to train
many categories of healthcare workers and lack
audit of compliance, as well as feedback of
audit and surveillance results in educational
sessions.
The findings of the present study have
important implications for future patient safety,
staff behaviour, health policy and research. At a
Consensus Conference held in Amsterdam, The
Netherlands, in November 2004, ARPAC data
were discussed, and consensus recommenda-
tions were developed [16]. Within the scope of
IC organisation and implementation, the follow-
ing priorities for national authorities and hospi-
tal management were identified: urgent action
should be taken to remove barriers, e.g., the
lack of sufficient numbers of skilled healthcare
personnel and isolation facilities; certified train-
ing in IC should be established; and urgent
action should be taken to ensure that acute-care
hospitals have adequate IC staffing levels, with
the SENIC study recommendations as a mini-
mum [16]. In an enlarging EU, where major
deficiencies in hospital infection programmes
are more pronounced in less affluent countries,
political commitment to improve patient safety
and contain antimicrobial resistance should
translate into stronger cooperation between
countries. Developing the evidence base for
prevention policies and sharing of best practice
should be conducted in partnership among
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professional organisations, governments and EU
agencies [16].
ACKNOWLEDGEMENTS
This work was supported by a grant from the European
Commission (QLK2-2001–00915). The information provided in
this publication does not necessarily reflect the position or
opinion of the European Commission. The authors’ work was
independent of the funders. Ethical approval was not required.
The colleagues from participating hospitals are gratefully
thanked for their dedicated participation and cooperative
efforts with this project.
REFERENCES
1. Struelens MJ. The epidemiology of antimicrobial resistance
in hospital acquired infections: problems and possible
solutions. BMJ 1998; 317: 652–654.
2. World Health Organization. WHO global strategy for con-
tainment of antimicrobial resistance. Geneva: WHO, 2001
(http://www.who.int/entity/csr/resources/publica-
tions/drugresist/en/EGlobal_Strat.pdf ).
3. Council of the European Union. Council Resolution of 8
June 1999 on antibiotic resistance. A strategy against the
microbial threat. Official J Europ Communities 1999; 41
(C195): 1–3.
4. Anonymous. World population datasheet. Washington, DC:
Population Reference Bureau, 2004.
5. Crombie IK, Davies HTO. Research in health care. Chiches-
ter: Wiley, 1996.
6. Haley RW, Culver DH, White JW et al. The efficacy of
infection surveillance and control programmes in pre-
venting nosocomial infections in US hospitals. Am J Epi-
demiol 1985; 121: 182–205.
7. Scheckler WE, Brimhall D, Buck AS et al. Requirements for
infrastructure and essential activities of infection control
and epidemiology in hospitals: a consensus panel report.
Society for Healthcare Epidemiology of America. Am J
Infect Control 1998; 26: 47–60.
8. Health Canada Nosocomial and Occupational Infections
Sections. Development of a resource model for infection
prevention and control programs in acute, long term, and
home care settings: conference proceedings of the infection
prevention and control alliance. Am J Infect Control 2004;
32: 2–6.
9. Voss A and Panel of ESGNI Members. The training cur-
riculum in infection control. Clin Microbiol Infect 2005; 11
(suppl 1): 33–35.
10. Richet H, Benbachir M, Brown D et al. Are there regional
variations in the diagnosis, surveillance, and control of
methicillin-resistant Staphylococcus aureus? Infect Control
Hosp Epidemiol 2003; 24: 334–341.
11. Zoutman DE, Ford BD, Brice E et al. Canadian Hospital
Epidemiology Committee. Canadian Nosocomial Infection
Surveillance Program, Health Canada. The state of infec-
tion surveillance and control in Canadian care. Am J Infect
Control 2003; 31: 266–272.
12. Nguyen GT, Proctor SZ, Sinkowitz-Cochran RL, Garrett
DO, Jarvis WR. Association for Professionals in Infection
Control and Epidemiology. Status of infection surveillance
and control programmes in the Unites States, 1992–96. Am
J Infect Control 2000; 28: 392–400.
13. Norrby SR, Carbon C. Report of Working Group 3: Spe-
cialist training and continuing medical education ⁄profes-
sional development in the infection disciplines. Clin
Microbiol Infect 2005; 11 (suppl 1): 46–49.
14. Pittet D, Hugonnet S, Barbath S et al. Effectiveness of a
hospital-wide programme to improve compliance with
hand hygiene. Lancet 2000; 356: 1307–1312.
15. Pittet D. Hand hygiene: improved standard and practice for
hospital care. Curr Opin Infect Dis 2003; 16: 327–335.
16. MacKenzie FM, Struelens MJ, Towner KJ, Gould IM, on
behalf of the ARPAC Steering Group and the ARPAC
Consensus Conference Participants. Report on the Con-
sensus Conference on Antibiotic Resistance Prevention
and Control. Clin Microbiol Infect 2005; 11: 937–954.
Struelens et al. Hospital infection control policies in Europe 737
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 729–737
